Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer

Published:2013-11 Issue:2 Volume:82 Page:266-270
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Sigel Keith,Lurslurchachai Linda,Bonomi Marcelo,Mhango Grace,Bergamo Cara,Kale Minal,Halm Ethan,Wisnivesky Juan

Funder

National Center for Research Resources

National Cancer Institute

Center for Advancing Translational Sciences

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. Revisions in the international system for staging lung cancer;Mountain;Chest,1997

2. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group;Sause;Chest,2000

3. Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301);Atagi;Lancet Oncol,2012

4. Lung cancer 7: management of lung cancer in elderly patients;Booton;Thorax,2003

5. Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians Evidence-based clinical practice guidelines;Ramnath;Chest,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic ablative radiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-07

2. STereotactic Ablative RadioTherapy in NEWly Diagnosed and Recurrent Locally Advanced Non-Small Cell Lung Cancer Patients Unfit for ConcurrEnt RAdio-Chemotherapy: Early Analysis of the START-NEW-ERA Non-Randomised Phase II Trial;International Journal of Radiation Oncology*Biology*Physics;2023-03

3. Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis;Frontiers in Oncology;2022-08-23

4. Prospective multicentre analysis of the therapeutic approach and prognostic factors determining overall survival in elderly patients with non-small-cell lung carcinoma treated with curative intent.;BJR|Open;2022-01

5. Excess mortality and undertreatment in elderly lung cancer patients: treatment nihilism in the modern era?;ERJ Open Research;2021-03-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3